CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-06 | RUSCKOWSKI STEPHEN H Director | Grant or award | +82,631 | $147.86 | $12.2M | 428,201 |
| 2023-03-06 | RUSCKOWSKI STEPHEN H Director | Shares withheld for taxes | −38,604 | $147.86 | $5.7M | 389,597 |
| 2023-03-03 | Doherty Catherine T. SVP, Regional Businesses | Sale | −717 | $140.63 | $101K | 67,810 |
| 2023-03-02 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −593 | $138.54 | $82K | 38,527 |
| 2023-03-01 | RUSCKOWSKI STEPHEN H Director | Shares withheld for taxes | −3,496 | $140.69 | $492K | 345,570 |
| 2023-03-01 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −320 | $140.69 | $45K | 39,120 |
| 2023-03-01 | Plewman Patrick SVP for Diagnostic Services | Shares withheld for taxes | −90 | $140.69 | $13K | 10,566 |
| 2023-03-01 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Shares withheld for taxes | −68 | $140.69 | $10K | 32,260 |
| 2023-03-01 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Shares withheld for taxes | −65 | $140.69 | $9K | 9,839 |
| 2023-03-01 | Doherty Catherine T. SVP, Regional Businesses | Shares withheld for taxes | −392 | $140.69 | $55K | 68,527 |
| 2023-03-01 | Davis J. E. CEO and President | Shares withheld for taxes | −1,292 | $140.69 | $182K | 95,466 |
| 2023-02-27 | Doherty Catherine T. SVP, Regional Businesses | Grant or award · Non-Qualifed Stock Option (right to buy) | +15,167 | 15,167 | ||
| 2023-02-24 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −1,415 | $141.42 | $200K | 39,440 |
| 2023-02-24 | Doherty Catherine T. SVP, Regional Businesses | Sale | −1,690 | $141.42 | $239K | 68,919 |
| 2023-02-23 | Davis J. E. CEO and President | Shares withheld for taxes | −1,473 | $147.86 | $218K | 79,315 |
| 2023-02-23 | Davis J. E. CEO and President | Grant or award | +17,443 | 96,758 | ||
| 2023-02-23 | Davis J. E. CEO and President | Grant or award · Non-Qualifed Stock Option (right to buy) | +68,956 | 68,956 | ||
| 2023-02-23 | RUSCKOWSKI STEPHEN H Director | Shares withheld for taxes | −5,826 | $147.86 | $861K | 329,007 |
| 2023-02-23 | RUSCKOWSKI STEPHEN H Director | Grant or award | +20,059 | 349,066 | ||
| 2023-02-23 | SAMAD SAM Executive Vice President & CFO | Grant or award | +4,710 | 20,384 |
Page 25 of 29 · 563 trades